In a study published in the journal Mammalian Biology on December 23, 2024, researchers compared the calls of Asian elephants ...

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

Finally, (Z)-endoxifen appears to deliver similar or even greater bone agonistic effects while resulting in little or no endometrial proliferative effects compared with standard treatments, like ...

According to a new publication in the Journal of Paleontology, a juvenile pterosaur vertebrae fossil, commonly known as a ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Adagene (NASDAQ:ADAG – Get Free Report) had its price objective increased by equities research analysts at HC Wainwright from $5.00 to $8.00 in a report issued on Monday,Benzinga reports. The ...

Analysts at HC Wainwright issued their FY2029 earnings per share estimates for Adagene in a research note issued to investors on Monday, January 27th. HC Wainwright analyst A. He anticipates that the ...

More information: Yeye Guo et al, Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells, Science Advances (2025). DOI ...

It would appear to be a city in ruins. The resounding chambers of the Perth Concert Hall fallen silent, its cinereous concrete facade and forecourts gated up and left to the weeds as the iconic ...

As we reflect on 2024, I am proud to share the remarkable progress Atossa Therapeutics has made in advancing our mission to address significant unmet needs in breast cancer prevention and treatment.